GO
Loading...

Enter multiple symbols separated by commas

Science

More

  • New Ebola estimate   Tuesday, 23 Sep 2014 | 10:57 AM ET
    New Ebola estimate

    CNBC's Meg Tirell reports the latest projections on the Ebola virus.

  • Ebola could infect 1.4 million by January Tuesday, 23 Sep 2014 | 10:41 AM ET

    The world's attention may have shifted to U.S. airstrikes on Syria, but West Africa continues to be ravaged by the worst outbreak of Ebola.

  • China drives world carbon emissions to record high Sunday, 21 Sep 2014 | 1:23 PM ET

    World carbon dioxide emissions will hit a record high this year, driven by China's growth and keeping the world far off track from the deep cuts needed to limit climate change, a study said on Sunday.

  • ReWalk 'life changing' for wounded U.S. Marine Captain

    Derek Herrera, wounded U.S. Marine Captain, discusses how ReWalk's wearable robotic exoskeleton device has impacted his life for the better and demonstrates the device.

  • FDA creates new category for exoskeletons   Wednesday, 17 Sep 2014 | 1:16 PM ET
    FDA creates new category for exoskeletons

    ReWalk CEO Larry Jasinski discusses just how big the market for wearable robotic exoskeleton devices could get.

  • Why it's so hard to call the end of a drought Tuesday, 16 Sep 2014 | 1:58 PM ET
    Drought

    Unlike a hurricane, tornado or snowstorm, the ends and beginning of droughts are very hard to predict.

  • Pharma in focus: Ebola & Enterovirus D68   Tuesday, 16 Sep 2014 | 1:31 PM ET
    Pharma in focus: Ebola & Enterovirus D68

    CNBC's Meg Tirrell runs down today's top health care headlines, including a major move by President Obama to fight the Ebola virus and the latest on Enterovirus D68.

  • Avanir up on Alzheimer's trial   Monday, 15 Sep 2014 | 1:03 PM ET
    Avanir up on Alzheimer's trial

    Avanir Pharma is up more than 60 percent, after the company said its drug was more effective in reducing agitation associated with Alzheimer's, compared with a placebo. CNBC's Meg Tirrell speaks to the company's CEO Keith Katkin.

  • 'I am a science geek!': 'Big Bang Theory' actress Thursday, 11 Sep 2014 | 1:17 PM ET
    Mayim Bialik headshot

    "Big Bang" actress Mayim Bialik is a self-proclaimed science geek (she has a Ph.D.) and wants to get kids excited about math and science.

  • Accelerating Ebola vaccine   Thursday, 4 Sep 2014 | 3:25 PM ET
    Accelerating Ebola vaccine

    CNBC's Meg Tirrell speaks to Johnson & Johnson chairman, Joaquin Duato, about J&J's partnership with the National Institutes of Health to fast track its Ebola vaccine program to begin human testing by early 2015.

  • Diabetes monitoring goes mobile   Thursday, 4 Sep 2014 | 2:38 PM ET
    Diabetes monitoring goes mobile

    Discussing the new ways to monitor glucose for people with diabetes, and competition in the space, with Terry Gregg, DexCom CEO. Gregg says his business is in conversations with Apple and Samsung in regards to partnering on wearables.

  • American doctor tests for Ebola: Report   Tuesday, 2 Sep 2014 | 1:00 PM ET
    American doctor tests for Ebola: Report

    CNBC's Meg Tirrell reports an American missionary doctor serving in Liberia has tested positive for Ebola.

  • Suddenly, nuclear fusion is drawing investor money Thursday, 28 Aug 2014 | 2:10 PM ET
    A Helion Energy prototype

    Two major tech investors have plowed $1.5 million into Helion Energy to help it develop a technology that hasn’t worked, according to Oilprice.com.

  • Ebola response roadmap   Thursday, 28 Aug 2014 | 1:52 PM ET
    Ebola response roadmap

    GlaxoSmithKline is to begin human testing of an experimental Ebola vaccine. CNBC's Meg Tirrell reports the World Health Organization has released a response roadmap with the goal of stopping the spread of Ebola in 6 to 9 months.

  • Kite Pharma's positive cancer drug study results   Wednesday, 27 Aug 2014 | 2:25 PM ET
    Kite Pharma's positive cancer drug study results

    Kite Pharma is working on a treatment which involves taking a cancer patient's own t-cells out of their body, genetically modifying them to better target cancer, and then re-administering them. Its CEO Arie Belldegrun, provides insight to the positive study with the therapy.

  • Roche's blockbuster pharma deal   Monday, 25 Aug 2014 | 3:47 PM ET
    Roche's blockbuster pharma deal

    CNBC's Meg Tirrell breaks down the mega deal between Swiss pharmaceutical firm Roche and InterMune for $8.3 billion.

  • Roche CEO: InterMune perfect strategic fit   Monday, 25 Aug 2014 | 11:18 AM ET
    Roche CEO: InterMune perfect strategic fit

    CNBC's Meg Tirrell speaks to Roche CEO Severin Schwan, and InterMune CEO Daniel Welch, about Roche's $8.3 billion acquisition of InterMune and the opportunity for the drug Esbriet in the U.S.

  • GPS discovers the West is so dry, it's rising Friday, 22 Aug 2014 | 4:59 PM ET
    California mountains dry lake

    California's mountains have risen more than half an inch, thanks to the absence of water to weigh them down, a study found. NBC News reports.

  • ALS raises over $13 million since July 29th   Monday, 18 Aug 2014 | 6:25 AM ET
    ALS raises over $13 million since July 29th

    CNBC's Andrew Ross Sorkin looks back on some of the best ice bucket challenge videos from last week, including from Bill Gates, saying the campaign has now hit China.

  • ALS stunned by millions of dollars   Friday, 15 Aug 2014 | 7:36 AM ET
    Guests on "The Tonight Show Starring Jimmy Fallon" participate in the 'Ice Bucket Challenge' on August 12, 2014.

    Lance Slaughter from the ALS Association, discusses the phenomenon spreading across social media to dump a bucket of ice over your head to raise awareness for ALS.